MedPage Today June 13, 2024
Mike Bassett

— AI detected 6.8% more clinically significant cancers, 20% fewer indolent cancers

An artificial intelligence (AI) system was better at detecting clinically significant prostate cancer on MRI compared with radiologists, a noninferiority, confirmatory study showed.

In a subset of 400 testing cases in which the AI system was compared with the radiologists participating in a reader study, the AI had an area under the receiver operating characteristic curve (AUROC) of 0.91 (95% CI 0.87-0.94) compared with 0.86 (95% CI 0.83-0.89) for the pool of 62 radiologists using the Prostate Imaging-Reporting and Data System version 2.1 (PI-RADS 2.1), reported Anindo Saha, MSc, of Radboud University Medical Center in Nijmegen, the Netherlands, and colleagues.

Therefore, the AI system passed the prespecified criteria...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Provider, Radiology, Technology
2024: record year for AI trials
2025: Provider organizations will embrace new AI and analytics techniques
AI and Automation in Healthcare – 2025 Health IT Predictions
Why The Public And Private Sectors Must Jointly Define Responsible AI
AI Crunches Clinical Notes to Highlight Care Improvement Opportunities

Share This Article